Avant Diagnostics (Avant Diagnostics) EV-to-EBIT : -2,968.97 (As of Apr. 27, 2024)

Avant Diagnostics EV-to-EBIT Chart

Avant Diagnostics Annual Data
	Trend	Oct09	Oct10	Oct11	Oct12	Oct13	Sep14	Sep15	Sep16	Sep17	Sep18
EV-to-EBIT		Get a 7-Day Free Trial					-6.13	-8.43	-4.67	-0.72	-4.44

Avant Diagnostics Quarterly Data
	Jan14	Apr14	Jul14	Oct14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18
EV-to-EBIT	Get a 7-Day Free Trial															-2.21	-2.02	-6.10	-4.44	-2.71

Competitive Comparison of Avant Diagnostics's EV-to-EBIT

For the Diagnostics & Research subindustry, Avant Diagnostics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avant Diagnostics's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avant Diagnostics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Avant Diagnostics's EV-to-EBIT falls into.

Avant Diagnostics EV-to-EBIT Calculation

Avant Diagnostics's EV-to-EBIT for today is calculated as:

Avant Diagnostics's current Enterprise Value is $7,416.48 Mil.
Avant Diagnostics's EBIT for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avant Diagnostics  (GREY:AVDX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Avant Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2018 is calculated as:

Avant Diagnostics's Enterprise Value for the quarter that ended in Dec. 2018 was $6.76 Mil.
Avant Diagnostics's EBIT for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avant Diagnostics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Avant Diagnostics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Avant Diagnostics (Avant Diagnostics) Business Description